Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Fosaprepitant Dimeglumine

    Client Email Product

    Fosaprepitant Dimeglumine

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    34
    US DMFs Filed

    US DMFs Filed

    16
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    3
    Other Certificates

    Other Certificates

    6
    Other Suppliers

    Other Suppliers

    23
    API REF. PRICE (USD / KG)
    20,627

    API Market Place

    0

    INTERMEDIATES
    3
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    24
    Europe

    Europe

    4
    Canada

    Canada

    1
    Australia

    Australia

    6
    South Africa

    South Africa

    1
    Uploaded Dossiers

    Uploaded Dossiers

    8
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    51.00

    Annual Reports

    0

    FDF Market Place

    1
    EXCIPIENTS
    26
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    1

    USFDA Exclusivities

    2
    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    30
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    left grey arrow
    right gray arrow
    • POWDER;INTRAVENOUS - EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    • POWDER;INTRAVENOUS - EQ 150MG BASE/VIAL
    Full View ScreenFull Screen View
    Enforcement Report - Week of January 31, 2024
    Enforcement Report - Week of January 31, 2024

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-31-2024-59527.pdf

    FDA
    31 Jan 2024
    Share Share
    Techdow USA and CTTQ Pharma Announce Collaboration Agreement
    Techdow USA and CTTQ Pharma Announce Collaboration Agreement

    https://www.businesswire.com/news/home/20230822632736/en

    BUSINESSWIRE
    22 Aug 2023
    Share Share
    Praxgen`s Fosaprepitant Dimeglumine Receives Approval in US
    Praxgen`s Fosaprepitant Dimeglumine Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213199

    FDA
    07 Oct 2021
    Share Share
    ASPIRO's Generic Fosaprepitant Dimeglumine Receives Tentative Approval In US
    ASPIRO's Generic Fosaprepitant Dimeglumine Receives Tentative Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214616

    FDA
    29 Jul 2021
    Share Share
    AChia Tai Tianqing Generic Fosaprepitant Dimeglumine Receives Approval in US
    AChia Tai Tianqing Generic Fosaprepitant Dimeglumine Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212143

    FDA
    08 Mar 2021
    Share Share
    Aurobindo Pharma`s Generic Fosaprepitant Dimeglumine Receives Approval In US
    Aurobindo Pharma`s Generic Fosaprepitant Dimeglumine Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210625

    FDA
    20 Jan 2021
    Share Share
    Qilu's Generic Fosaprepitant Dimeglumine Receives Approval In US
    Qilu's Generic Fosaprepitant Dimeglumine Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213106

    FDA
    08 Sep 2020
    Share Share
    Accord Hlthcare’s Generics Fluoxetine Hydrochloride Receives Approval In US
    Accord Hlthcare’s Generics Fluoxetine Hydrochloride Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204025

    FDA
    27 Aug 2020
    Share Share
    Navinta's Generic Fosaprepitant Dimeglumine Receives Approval In US
    Navinta's Generic Fosaprepitant Dimeglumine Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212957

    FDA
    20 Aug 2020
    Share Share
    Enforcement Report - Week of July 22, 2020
    Enforcement Report - Week of July 22, 2020

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-22-2020-1595395565.pdf

    FDA
    22 Jul 2020
    Share Share
    Sandoz acquires US distribution rights to two key hospital injectable medicines
    Sandoz acquires US distribution rights to two key hospital injectable medicines

    https://www.prnewswire.com/news-releases/sandoz-acquires-us-distribution-rights-to-two-key-hospital-injectable-medicines-reinforcing-strategic-focus-on-key-growth-segment-301028154.html

    PR NEWSWIRE
    23 Mar 2020
    Share Share
    Fresenius Kabi Announces Availability of Fosaprepitant for Injection
    Fresenius Kabi Announces Availability of Fosaprepitant for Injection

    https://www.businesswire.com/news/home/20191113005162/en

    BUSINESSWIRE
    13 Nov 2019
    Share Share
    Dr Reddys launches generic Emend in US market
    Dr Reddys launches generic Emend in US market

    https://www.moneycontrol.com/news/business/dr-reddys-launches-generic-emend-in-us-market-4427731.html

    MONEYCONTROL
    11 Sep 2019
    Share Share
    Lupin's Generic Fosaprepitant Dimeglumine Receives Approval in US
    Lupin's Generic Fosaprepitant Dimeglumine Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210689

    FDA
    10 Sep 2019
    Share Share
    MSN labs to launch two new generics in USA
    MSN labs to launch two new generics in USA

    https://www.thepharmaletter.com/in-brief/brief-msn-labs-to-launch-two-new-generics-in-usa

    THEPHARMALETTER
    06 Sep 2019
    Share Share
    SunGen Pharma Receives Seventh ANDA Approval from US FDA
    SunGen Pharma Receives Seventh ANDA Approval from US FDA

    http://www.globenewswire.com/news-release/2019/09/06/1912003/0/en/SunGen-Pharma-Receives-Seventh-ANDA-Approval-from-US-FDA.html

    GLOBENEWSWIRE
    06 Sep 2019
    Share Share
    MSN Labs Generic Fosaprepitant Dimeglumine Receives Approval In US
    MSN Labs Generic Fosaprepitant Dimeglumine Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209965

    FDA
    06 Sep 2019
    Share Share
    Teva Pharms' Generic Fosaprepitant Receives Approval in US
    Teva Pharms' Generic Fosaprepitant Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210064

    FDA
    05 Sep 2019
    Share Share
    Novadoz Pharma /MSN Labs Receives FDA Clearance for Fosaprepitant & Decitabine
    Novadoz Pharma /MSN Labs Receives FDA Clearance for Fosaprepitant & Decitabine

    https://www.prnewswire.com/news-releases/novadoz-pharmaceuticalsmsn-labs-receives-fda-clearance-for-fosaprepitant-and-decitabine-the-companys-first-generic-specialty-injectable-products-300912919.html

    PR NEWSWIRE
    05 Sep 2019
    Share Share
    Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
    Copycats wanted: Pfizer, AZ and more under threat as China solicits generics

    https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic

    Angus Liu FIERCE PHARMA
    21 Jun 2019
    Share Share
    Lupin`s Generic Fosaprepitant Dimeglumine Receives Tentative Approval in US
    Lupin`s Generic Fosaprepitant Dimeglumine Receives Tentative Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210689

    FDA
    08 May 2019
    Share Share
    Lupin receives US FDA tentative marketing approval for generic Emend for Inj
    Lupin receives US FDA tentative marketing approval for generic Emend for Inj

    http://www.pharmabiz.com/NewsDetails.aspx?aid=115605&sid=2

    PHARMABIZ
    07 May 2019
    Share Share
    Heron Announces FDA Approval of sNDA to Expand CINVANTI® Label for IV Push
    Heron Announces FDA Approval of sNDA to Expand CINVANTI® Label for IV Push

    https://www.prnewswire.com/news-releases/heron-announces-fda-approval-of-supplemental-new-drug-application-to-expand-cinvanti-label-for-iv-push-300802594.html

    PR NEWSWIRE
    26 Feb 2019
    Share Share
    Msn Lab's Generic Fosaprepitant Dimeglumine Receives Tentative Approval in US
    Msn Lab's Generic Fosaprepitant Dimeglumine Receives Tentative Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209965

    FDA
    28 Jan 2019
    Share Share
    Six medicines recommended for approval, including one orphan
    Six medicines recommended for approval, including one orphan

    http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/03/news_detail_002925.jsp&mid=WC0b01ac058004d5c1

    EMA
    24 Mar 2018
    Share Share
    Emend®(Fosaprepitant Dimeglumine): Merck Sharp & Dohme Corp. V. MSN Laboratories
    Emend®(Fosaprepitant Dimeglumine): Merck Sharp & Dohme Corp. V. MSN Laboratories

    https://insight.rpxcorp.com/litigation_documents/12773079

    PATENT LITIGATION
    16 Jan 2018
    Share Share
    Heron takes on Merck's Emend with FDA win for antinausea drug Cinvanti
    Heron takes on Merck's Emend with FDA win for antinausea drug Cinvanti

    http://www.fiercepharma.com/marketing/heron-takes-merck-s-emend-fda-win-for-antinausea-drug-cinvanti

    Carly Helfand FIERCE PHARMA
    11 Nov 2017
    Share Share
    Glenmark gets US FDA nod for generic of Emend capsules
    Glenmark gets US FDA nod for generic of Emend capsules

    http://www.indiainfoline.com/article/news-top-story/glenmark-gets-us-fda-nod-for-generic-of-emend-capsules-117101700271_1.html

    INDIAINFOLINE
    16 Oct 2017
    Share Share
    Sagent Pharms Generic Fosaprepitant Dimeglumine Receives Tentative Approval In US
    Sagent Pharms Generic Fosaprepitant Dimeglumine Receives Tentative Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204845

    FDA
    28 Mar 2017
    Share Share
    Facing off rivals, Merck looks to expand CINV label on positive PhIII Emend study
    Facing off rivals, Merck looks to expand CINV label on positive PhIII Emend study

    http://www.fiercebiotech.com/story/facing-rivals-merck-looks-expand-cinv-label-positive-phiii-emend-study/2015-06-29

    John Carroll FIERCE BIOTECH
    29 Jun 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search